Role of MRP1 in multidrug resistance in acute myeloid leukemia

被引：0
|
作者：
O Legrand
R Zittoun
J-P Marie
机构：
[1] EA1529,
[2] Université Paris 6,undefined
[3] Formation de Recherche Claude Bernard,undefined
[4] and Service d’Hématologie,undefined
[5] Hôpital Hôtel-Dieu,undefined
[6] AP-HP,undefined
来源：
Leukemia | 1999年 / 13卷
关键词：
MDR; MRP1; acute myeloid leukemia; functional test; prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The best characterized resistance mechanism in adult acute myeloid leukemia (AML) is the one mediated by the MDR1 gene which has been shown to be associated with poor outcome. However, alternative proteins such as the more recently recognized multidrug-associated protein (MRP1), may also contribute to the resistance to anthracyclines and etoposide in AML. Recently, the role of this protein was discussed and was unclear in AML. However, recent data concerning the functionality and the modulation of the activity of MRP1 may elucidate its role in comparison with other mechanisms of resistance. In this paper, we will review these recent data concerning the role of MRP1 in adult AML.
引用
收藏
页码：578 / 584
页数：6
相关论文
共 50 条
  • [1] Role of MRP1 in multidrug resistance in acute myeloid leukemia
    Legrand, O
    Zittoun, R
    Marie, JP
    LEUKEMIA, 1999, 13 (04) : 578 - 584
  • [2] Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia:: the impact on MRP activity
    van der Kolk, DM
    Vellenga, E
    van der Veen, AY
    Noordhoek, L
    Timmer-Bosscha, H
    Ossenkoppele, GJ
    Raymakers, RA
    Müller, M
    van den Berg, E
    de Vries, EGE
    BLOOD, 2000, 95 (11) : 3514 - 3519
  • [3] Multidrug resistance protein MRP1, glutathione, and related enzymes -: Their importance in acute myeloid leukemia
    van der Kolk, DM
    Vellenga, E
    Müller, M
    de Vries, EGE
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III, 1999, 457 : 187 - 198
  • [4] Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: The impact on MRP activity.
    van der Kolk, DM
    Vellenga, E
    van der Veen, AY
    Noordhoek, L
    Timmer-Bosscha, H
    Ossenkoppele, GJ
    Raymakers, R
    Muller, M
    van den Berg, E
    de Vries, EGE
    BLOOD, 1999, 94 (10) : 197B - 197B
  • [5] Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16:: expression of MRP1 homologues
    van der Kolk, DM
    de Vries, EGE
    Vellenga, E
    LEUKEMIA, 2001, 15 (01) : 191 - 192
  • [6] Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16: expression of MRP1 homologues
    DM van der Kolk
    EGE de Vries
    E Vellenga
    Leukemia, 2001, 15 : 191 - 192
  • [7] Activity and expression of the multidrug resistance protein MRP1 and MRP2 in acute myeloid leukemia (AML) cells.
    VanderKolk, DM
    deVries, EGE
    Koning, JA
    VandenBerg, E
    Muller, M
    Vellenga, E
    BLOOD, 1997, 90 (10) : 801 - 801
  • [8] THE EXPRESSION OF MULTIDRUG RESISTANCE GENES (MDR1, MRP1, BCRP, LRP) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Cioch, M.
    Kocki, J.
    Jarosz, M.
    Dmoszynska, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 533 - 533
  • [9] The role of MRP1 in the multidrug resistance of colorectal cancer
    Cao, Dongxing
    Qin, Shaolan
    Mu, Yifei
    Zhong, Ming
    ONCOLOGY LETTERS, 2017, 13 (04) : 2471 - 2476
  • [10] Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact
    K Döhner
    RF Schlenk
    BA van der Reijden
    H Döhner
    Leukemia, 2000, 14 : 1154 - 1154
12345